Recurrent Subclinical Tuberculosis Among Antiretroviral Therapy-Accessing Participants: Incidence, Clinical Course, and Outcomes.
Recurrent Subclinical Tuberculosis Among Antiretroviral Therapy-Accessing Participants: Incidence, Clinical Course, and Outcomes.
复制标题
DOI:
10.1093/cid/ciac185
复制
发表时间:
2022-10-29
期刊:
影响因子:
--
通讯作者:
Karim SA
中科院分区:
文献类型:
--
作者:
Naidoo K;Moodley MC;Hassan-Moosa R;Dookie N;Yende-Zuma N;Perumal R;Dawood H;Mvelase NR;Mathema B;Karim SA
Undiagnosed asymptomatic subclinical tuberculosis (TB) remains a significant threat to global TB control, accounting for a substantial proportion of cases among people living with human immunodeficiency virus (HIV)/AIDS (PLWHA). We determined incidence, progression, and outcomes of subclinical TB in antiretroviral therapy (ART)–accessing PLWHA with known previous TB in South Africa. A total of 402 adult PLWHA previously treated for TB were enrolled in the prospective Centre for the AIDS Programme of Research in South Africa TRuTH (TB Recurrence Upon TB and HIV treatment) Study. Participants were screened for TB with quarterly clinical and bacteriologic evaluation and biannual chest radiographs over 36 months. Those with suspected or confirmed TB were referred to the National TB Programme. Participants received HIV services, including ART. Incidence rate of TB was estimated using Poisson regression and descriptive statistical analyses summarized data. A total of 48 of 402 (11.9%) bacteriologically confirmed incident recurrent TB cases were identified, comprising 17 of 48 (35.4%) subclinical TB cases and 31 of 48 (64.5%) clinical TB cases. Age, sex, and body mass index were similar among subclinical, clinical, and no TB groups. Incidence rates (95% Confidence Interval [CI]) of recurrent TB overall, in clinical and subclinical TB groups were 2.3 (1.7-3.0), 1.5 (1.1-2.2), and 0.9 (0.5-1.4) per 100 person-years, respectively. In the subclinical TB group, 14 of 17 (82.4%) were diagnosed by TB culture only, 11 of 17 (64.7%) received TB treatment, and 6 of 17 (35.3%) resolved TB spontaneously. High incidence rates of recurrent subclinical TB in PLWHA highlight inadequacies of symptom-based TB screening in high TB–HIV burden settings. Undiagnosed asymptomatic subclinical tuberculosis (TB) threatens global TB control. Similarly high incidence rates of recurrent clinical and subclinical TB in people living with human immunodeficiency virus/AIDS highlight inadequacies of symptom-based TB screening in high-burden settings.
登录
查看更多内容
影响因子:
10
作者:
Ralph, Anna P.;Ardian, Muhamed;Kelly, Paul M.
通讯作者:
Kelly, Paul M.
影响因子:
82.9
作者:
Esmail, Hanif;Lai, Rachel P.;Lesosky, Maia;Wilkinson, Katalin A.;Graham, Christine M.;Coussens, Anna K.;Oni, Tolu;Warwick, James M.;Said-Hartley, Qonita;Koegelenberg, Coenraad F.;Walzl, Gerhard;Flynn, JoAnne L.;Young, Douglas B.;Barry, Clifton E., III;O'Garra, Anne;Wilkinson, Robert J.
通讯作者:
Wilkinson, Robert J.
影响因子:
3.7
作者:
Tiemersma EW;van der Werf MJ;Borgdorff MW;Williams BG;Nagelkerke NJ
通讯作者:
Nagelkerke NJ
DOI:
10.1183/20734735.0079-2021
发表时间:
2021-09
期刊:
Breathe (Sheffield, England)
影响因子:
--
作者:
Migliori GB;Ong CWM;Petrone L;D'Ambrosio L;Centis R;Goletti D
通讯作者:
Goletti D
影响因子:
11.8
作者:
O'Shea, Matthew K.;Koh, Gavin C. K. W.;Dedicoat, Martin
通讯作者:
Dedicoat, Martin